Raymond James Trust N.A. Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Raymond James Trust N.A. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 69,926 shares of the healthcare conglomerate’s stock after purchasing an additional 3,805 shares during the quarter. UnitedHealth Group makes up approximately 0.8% of Raymond James Trust N.A.’s portfolio, making the stock its 24th biggest position. Raymond James Trust N.A.’s holdings in UnitedHealth Group were worth $35,611,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Wedgewood Investors Inc. PA purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $301,000. Capital Advisors Ltd. LLC boosted its stake in UnitedHealth Group by 7.1% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 1,818 shares of the healthcare conglomerate’s stock worth $926,000 after purchasing an additional 121 shares during the period. Northcape Wealth Management LLC increased its stake in UnitedHealth Group by 3.4% in the second quarter. Northcape Wealth Management LLC now owns 4,277 shares of the healthcare conglomerate’s stock valued at $2,178,000 after purchasing an additional 142 shares during the period. AMG National Trust Bank grew its holdings in shares of UnitedHealth Group by 8.9% during the second quarter. AMG National Trust Bank now owns 16,895 shares of the healthcare conglomerate’s stock worth $8,604,000 after buying an additional 1,383 shares during the last quarter. Finally, Tempus Wealth Planning LLC lifted its position in UnitedHealth Group by 20.2% during the 2nd quarter. Tempus Wealth Planning LLC now owns 784 shares of the healthcare conglomerate’s stock worth $399,000 after acquiring an additional 132 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.0 %

UNH traded up $5.79 on Friday, reaching $584.51. 2,376,416 shares of the company’s stock were exchanged, compared to its average volume of 3,156,778. The company has a market cap of $539.75 billion, a price-to-earnings ratio of 35.73, a PEG ratio of 1.61 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $591.54. The company’s 50 day moving average is $537.83 and its 200-day moving average is $509.89.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the previous year, the business posted $6.14 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Robert W. Baird raised their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Monday, August 19th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.